New Animal Drugs; Withdrawal of Approval of New Animal Drug Applications

Federal Register, Volume 83 Issue 62 (Friday, March 30, 2018)

Federal Register Volume 83, Number 62 (Friday, March 30, 2018)

Rules and Regulations

Pages 13637-13638

From the Federal Register Online via the Government Publishing Office www.gpo.gov

FR Doc No: 2018-06357

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 522

Docket No. FDA-2017-N-0002

New Animal Drugs; Withdrawal of Approval of New Animal Drug Applications

AGENCY: Food and Drug Administration, HHS.

ACTION: Notification of withdrawal.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval of three new animal drug applications (NADAs). This action is being taken at the sponsors' request because these products are no longer manufactured or marketed.

DATES: Withdrawal of approval is effective April 9, 2018.

FOR FURTHER INFORMATION CONTACT: Sujaya Dessai, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-5761, email protected.

SUPPLEMENTARY INFORMATION: During July and August 2017, the following sponsors requested that FDA withdraw approval of the NADAs listed in the following table because the products are no longer manufactured or marketed:

----------------------------------------------------------------------------------------------------------------

File No. Sponsor Product name 21 CFR section

----------------------------------------------------------------------------------------------------------------

047-055............................. Watson Laboratories, Inc., Chorionic Gonadotropin 522.1081

311 Bonnie Circle, Corona, Powder for Injection.

CA 92880.

Page 13638

104-606............................. Watson Laboratories, Inc., Dexamethasone Sodium 522.540

311 Bonnie Circle, Corona, Phosphate Injection.

CA 92880.

139-633............................. Wildlife Laboratories, Inc., WILDNIL (carfentanil 522.300

1230 W. Ash St., suite D, citrate) Injection.

Windsor, CO 80550.

----------------------------------------------------------------------------------------------------------------

Therefore, under authority delegated to the Commissioner of Food and Drugs, and in accordance with Sec. 514.116 Notice of withdrawal of approval of application (21 CFR 514.116), notice is given that approval of NADAs 047-055, 104-606, and 139-633, and all supplements and amendments thereto, is hereby withdrawn, effective April 9, 2018.

Elsewhere in this issue of the Federal Register, FDA is amending the animal drug regulations to reflect the voluntary withdrawal of approval of these applications.

Dated: March 21, 2018.

Leslie Kux,

Associate Commissioner for Policy.

FR Doc. 2018-06357 Filed 3-29-18; 8:45 am

BILLING CODE 4164-01-P

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT